4277 related articles for article (PubMed ID: 6222844)
1. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
Sava G; Giraldi T
Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
[TBL] [Abstract][Full Text] [Related]
2. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
4. Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.
Sava G; Giraldi T; Perissin L; Zorzet S; Decorti G
Clin Exp Metastasis; 1987; 5(1):27-34. PubMed ID: 2951046
[TBL] [Abstract][Full Text] [Related]
5. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
6. Review of experimental studies on nitrosourea derivatives in Japan.
Tsukagoshi S
Recent Results Cancer Res; 1980; 70():107-17. PubMed ID: 7355242
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.
Edanami K; Komiyama K; Kuroda T; Umezawa I
Cancer Chemother Pharmacol; 1984; 13(1):22-6. PubMed ID: 6234104
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of 3-[3-(2-chloroethyl)-3-nitrosoureido]-3-deoxy-D-glucopyranose on murine tumors.
Komiyama K; Edanami K; Kuroda T; Umezawa I
Gan; 1981 Feb; 72(1):53-9. PubMed ID: 6456168
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
[TBL] [Abstract][Full Text] [Related]
12. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
Sava G; Zorzet S; Mestroni G; Zassinovich G
Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
[TBL] [Abstract][Full Text] [Related]
15. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
Fujimoto S; Wang Y; Inoue K; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of Bioactivity of the Russian-Made Antitumor Substances of the Nitrosourea Group.
Bunyatyan ND; Oborotova NA; Nikolaeva LL; Saprykina NS; Borisova LM; Kiseleva MP; Prokof'ev AB
Bull Exp Biol Med; 2019 Feb; 166(4):456-460. PubMed ID: 30810868
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
[TBL] [Abstract][Full Text] [Related]
19. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
20. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
Mayo JG; Laster WR; Andrews CM; Schabel FM
Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
